These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18412298)

  • 1. Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
    Dubosc AE; Perroud AM; Bagot M; Farenq V; Chevalier X; Maitre B; Claudepierre P
    J Rheumatol; 2008 Jun; 35(6):1222-3. PubMed ID: 18412298
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
    Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
    J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
    [No Abstract]   [Full Text] [Related]  

  • 3. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
    Marakli SS; Uzun S; Ozbek S; Tuncer I
    Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
    Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
    Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-associated palmoplantar pustulosis.
    Pyrpasopoulou A; Chatzimichailidou S; Simoulidou E; Aslanidis S
    J Clin Rheumatol; 2010 Apr; 16(3):138-9. PubMed ID: 20216329
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythema nodosum associated with infliximab therapy.
    Rosen T; Martinelli P
    Dermatol Online J; 2008 Apr; 14(4):3. PubMed ID: 18627725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of infliximab-induced psoriasis.
    Richetta A; Mattozzi C; Carlomagno V; Maiani E; Carboni V; Giancristoforo S; D'Epiro S; Bruni F; Calvieri S
    Dermatol Online J; 2008 Nov; 14(11):9. PubMed ID: 19094847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study.
    Davaine AC; Saraux A; Prigent S; Kupfer-Bessaguet I; Roswag D; Plantin P; Schoenlaub P; Talarmin F; Zagnoli A; Misery L
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1471-7. PubMed ID: 18713230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
    Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab.
    Simón JA; Burgos-Vargas R
    Dermatology; 2008; 216(3):234-5. PubMed ID: 18182816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
    Kain T; MacGregor D; Buchanan RR; de Jager JP; Schachna L
    Ann Rheum Dis; 2008 Jun; 67(6):899-900. PubMed ID: 18474663
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse cutaneous reactions to tumour necrosis factor alpha antagonists.
    Zardawi IM
    Pathology; 2013 Aug; 45(5):521-3. PubMed ID: 23856847
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory vertebral sarcoidosis responding to infliximab.
    Garg S; Garg K; Altaf M; Magaldi JA
    J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis.
    Ngai JC; Lam R; Ko FW; To KW; Hui DS
    Thorax; 2009 Feb; 64(2):184. PubMed ID: 19176849
    [No Abstract]   [Full Text] [Related]  

  • 16. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 18. Could tumour necrosis factor blockers inhibit the progression of future structural damage in ankylosing spondylitis?
    Gaspersic N; Sersa I; Jevtic V; Tomsic M; Praprotnik S
    Ann Rheum Dis; 2008 Sep; 67(9):1354. PubMed ID: 18697784
    [No Abstract]   [Full Text] [Related]  

  • 19. Remission and time of resolution of nail psoriasis during infliximab therapy.
    Bianchi L; Bergamin A; de Felice C; Capriotti E; Chimenti S
    J Am Acad Dermatol; 2005 Apr; 52(4):736-7. PubMed ID: 15793554
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
    Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
    Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.